Can't get over this amazing feat of engineering in Pittsburgh, where a new bridge was built next to the old one and then literally slid into place. AND it's opening early, which never happens with construction projects. www.axios.com/local/pittsb...

US measles cases have officially surpassed last year's count and it's only *checks calendar* July. 2026 to date: 2,318 2025 full year: 2,289 www.cdc.gov/measles/data...

Great context here from @melodyschreiber.com on how cuts to public health funding trickle down to states. Michigan is experiencing the most cyclospora cases right now with more than 6,100 as of this morning. www.theguardian.com/society/2026...

I hope you read to the end because I'm really proud of this kicker.

Reminder that @wired.com remains interested in what’s going on at HHS. If you’re an employee and would like to pass on a tip, you can reach me at emullin.06 on Signal.

This is the most bizarre interaction I've ever had with an HHS spokesperson. From my story on CDC's pivot to "shared-decision making" for vaccines, with insight from @jennifernuzzo.bsky.social and @jakescottmd.bsky.social: www.wired.com/story/why-rf...

This is the unfortunate fallout when a major magazine fails to label fiction as such. Rogers is a member of RFK Jr.'s new autism committee.

Ironically, this law change was proposed by Republicans as a way to keep the CDC in check: www.schmitt.senate.gov/media/press-...

Some cool science stories trending at @wired.com right now (though I may be biased). Go ahead and give 'em a read: www.wired.com

It's been nearly two years since the first gene-editing therapy, Casgevy, was approved for sickle cell disease. Just 39 patients worldwide have received it in that time. This is from a Nov. 10 update from manufacturer Vertex:

Over on the other site, gene-editing scientist Lucas Harrington announced a new company to explore "preventive gene editing." In case you're counting, this is the third startup openly pursuing plans to edit human embryos. More on the company here: www.preventive.bio/blog/announc...

Day 2 of ACIP: The committee just voted 11-1 in favor of tabling the hepatitis B vaccine issue. This was the anticipated vote language:

The National Review, a leading conservative magazine, tells RFK Jr., "Don't abandon mRNA." www.nationalreview.com/2025/08/dont...

The funny thing about this DEI reporting form that was sent to HHS employees yesterday is that literally anyone on the internet can fill it out: forms.office.com/pages/respon...

Hmm, I thought AI was supposed to speed up the FDA's review process?

Former CEO of 23andMe Anne Wojcicki won her company back late Friday with a $305 million offer made through a new nonprofit she established, TTAM Research Institute. Here's what Wojcicki is promising customers: investors.23andme.com/news-release...

(2/3) It's not a new feat. Here's a participant from a 2012 study using a brain-computer interface (BCI) to control a robotic arm to drink from a bottle. See the pedestal and wire on her head? Not exactly ideal for everyday use.